ID	DisplayName	Authors	Year	Title	Publication	PublicationLocation	WebLink
Lenz_et_al_2010	Lenz et al., 2010	Lenz O, Verbinnen T, Lin TI, Vijgen L, Cummings MD, Lindberg J, Berke JM, Dehertogh P, Fransen E, Scholliers A, Vermeiren K, Ivens T, Raboisson P, Edlund M, Storm S, Vrang L, de Kock H, Fanning GC, Simmen KA	2010	In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435	Antimicrobial Agents and Chemotherapy	54(5):1878-87	http://aac.asm.org/content/54/5/1878.long
Lenz_et_al_2013	Lenz et al., 2013	Lenz O, Vijgen L, Berke JM, Cummings MD, Fevery B, Peeters M, De Smedt G, Moreno C, Picchio G	2013	Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)	Journal of Hepatology	58(3):445-51	http://www.sciencedirect.com/science/article/pii/S016882781200829X
Pilot_Matias_et_al_2015	Pilot-Matias et al., 2015	Pilot-Matias T, Tripathi R, Cohen D, Gaultier I, Dekhtyar T, Lu L, Reisch T, Irvin M, Hopkins T, Pithawalla R, Middleton T, Ng T, McDaniel K, Or YS, Menon R, Kempf D, Molla A, Collins C	2015	In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450	Antimicrobial Agents and Chemotherapy	59(2):988-97	http://aac.asm.org/content/59/2/988.long